| Característica |
Objectiu de la convocatòria
The AACR-CRI Lloyd J. Old Award in Cancer Immunology was established to honor the memory of the late Lloyd J. Old and will recognize an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
• Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
• Marta López, mlopez4@imim.es Ext.: 1576
|
Convocatòria (URL)
http://www.aacr.org/Research/Awards/Pages/Awards-Detail.aspx?ItemId=2#.WyNkvaeHJAl
|
Impresos (URL)
Nominations:
https://myaacr.aacr.org
|
Requisits
The award is open to all cancer immunologists who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
Eligible candidates will be considered on the basis of their outstanding and innovative research, which has had a major impact on the cancer field, and which has the potential to stimulate new directions in cancer immunology.
Candidates must currently maintain an active research program, have a record of recent publications, and be able to present an award lecture at the AACR annual meeting 2020.
The award will be presented to an individual investigator.
Institutions and/or organizations are not eligible to receive the Award.
Institutions or organizations are not eligible for the award.
|
Dotació
The recipient of the award will receive an honorarium of $10,000, give an award lecture during the AACR Annual Meeting 2020 in San Diego, California, and will be provided support for the winner and a guest to attend the AACR Annual Meeting 2020.
|
Documentació
Nomination materials to be submitted are:
A nomination letter written in English (Max: 1,000 words), which
comprehensively describes the candidate’s outstanding and innovative research.
Letter must specifically outline the candidate’s current research activity and
indicate how their research holds promise for continued substantive
contributions to the cancer field and new directions in cancer immunology. All
publications that directly support the mentioned research accomplishments
must be referenced within the provided letter.
A brief scientific citation (Max: 50 words) highlighting the major scientific
contribution(s) justifying the award candidate’s nomination.
|